9:41
immunovant.com
Screenshot of immunovant.com
immunovant.com favicon

immunovant.com

13 technologies
VerifiedGrowingVisit11.1K/mo$17M43813 Tech25 Leads
Deep Dive

Immunovant: The $200M Bet on One Target

A biotech startup with a laser focus, a small team, and a massive war chest.

In the high-stakes world of biotech, where diversification is often seen as safety, Immunovant is betting everything on a single molecule. With $200M in funding and a pipeline laser-focused on FcRn inhibition, this isn't a company hedging its bets—it's a company doubling down on a specific mechanism to treat autoimmune diseases.

$200M
Total Funding
438
Employees
$16.9M
Annual Revenue
43%
Direct Traffic

"Immunovant isn't playing the numbers game; they're playing the precision game. $200M behind a single target is either visionary or reckless."

The Lean Machine

For a company with $200M in funding, Immunovant operates with surprising efficiency. At 438 employees, they maintain a lean operational structure compared to traditional biotechs of similar capitalization. This suggests a heavy reliance on external partnerships and a focus on core R&D rather than building massive internal infrastructure. The revenue figure of $16.9M is likely milestone payments or early-stage collaboration revenue, not commercial sales—highlighting they are still in the pre-revenue growth phase.

Traffic & Visibility

With 11,120 monthly visits and a global rank hovering around 2.2M, Immunovant isn't a household name—and that's expected for a clinical-stage biotech. However, the traffic composition is telling: 43% direct traffic indicates strong brand recall among investors and industry insiders. The 41% organic search traffic is driven by high-intent keywords like 'immunovant pipeline' and 'immunovant revenue,' suggesting the audience isn't casual browsers; they are analysts, investors, and biotech professionals tracking the company's progress.

The tech stack reveals a modern, performant website built with Tailwind CSS and Bootstrap, utilizing jQuery for interactivity and GSAP for animations. It's a clean, corporate site designed for clarity rather than flashiness. The absence of social profiles in the data suggests a B2B/investor-focused digital strategy, prioritizing LinkedIn and press releases over Twitter or Instagram engagement.

  • Single-target focus (FcRn) reduces complexity but increases risk.
  • High capital efficiency: $200M funding vs. 438 employees.
  • Investor-grade traffic: High direct traffic signals strong institutional interest.
  • CEO Pete Salzmann leads a lean executive team focused on pipeline execution.
Does not diversify across multiple drug candidates.
Specialized focus allows for deep expertise in FcRn inhibition.
Lacks broad consumer brand presence or social media engagement.
Strong institutional backing with $200M in funding.
Not yet generating commercial revenue from products.
Website optimized for investor relations and clinical updates.

The Verdict: High Stakes, High Reward

Immunovant is a pure-play biotech for investors who believe in the FcRn mechanism. It's not for the faint of heart, but the capital efficiency and focus are compelling.

What tech stack does Immunovant use?

19 detected
CDN1
JavaScript Libraries3
Tracking & Analytics6
G
Google Tag Manager
A
Amazon CloudFront
C
Cloudflare
G
Google Tag Manager
G
Google Analytics
G
Google DoubleClick

How much traffic does Immunovant get?

Traffic & Engagement

11.1K
Monthly Visits
1.5
Pages/Visit
0:12
Avg. Duration
39%
Bounce Rate
Monthly Traffic Trend+15%
9.6K
Oct 2025
Oct
8.2K
Nov 2025
Nov
11.1K
Dec 2025
Dec

Traffic Sources

Search
41%
Direct
43%
Social
8%
Referrals
7%
Email
0%
Paid
1%

Where is Immunovant's audience located?

🌍65.9%
🌍19.5%
🌍11.0%
🌍3.6%

What keywords does Immunovant rank for?

5 keywords
1immunovant420 vol$1.16
2immunovant pipeline170 vol
3immunovant revenue130 vol
4immuvant120 vol
5immunvant ted90 vol

How is Immunovant's SEO?

Open Graph Image

OG Image preview
og:image

https://d1io3yog0oux5.cloudfront.net/_2520548587927c961f4af0d7e7ad7451/immunovant/db/950/8034/social_image_resized.jpg

Meta Tags

title23 chars

Immunovant, Inc. (IMVT)

og:title

Immunovant, Inc.

languageEN

H1 Tags

h1Immunovant, Inc.

Schema Types

Corporation

What is Immunovant's revenue?

$17M
Annual Revenue
438
58%
Employees
$39K
Revenue/Employee
$200M
Total Funding
$904M
Valuation
#8,706
Growjo Rank
Biotech
New York, United States
Headquarters

Who works at Immunovant?

Loading leads...

What do customers think of Immunovant?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Immunovant

What is Immunovant's Revenue?
Immunovant generates approximately $17M in annual revenue. With 438 employees, that's $38,573 per employee. The company has raised $200M in total funding.
How fast is Immunovant growing?
Immunovant employee count has changed by 58% year over year.
What technologies does Immunovant use?
Immunovant uses 13 technologies across their website including CDN, Cloud & Hosting, Analytics & Marketing. Key technologies include cdnjs, AWS CloudFront, Cloudflare, Google Tag Manager, Google Analytics.
Who are Immunovant's competitors?
Immunovant's main competitors include Buffalo BioLabs, Seed Therapeutics, KSL Diagnostics, Genencor International, IpiNovyx Bio. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

How to contact Immunovant?

Contact Information

What are Immunovant's key pages?

Export immunovant.com Data

Download the complete tech stack, analytics, leads, and company data for immunovant.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About immunovant.com

Company Overview

immunovant.com
Website
health
Industry
#2,215,539
Global Rank
11.1K
Monthly Visitors
13
Technologies
25+
Employees

immunovant.com Key Pages

Contact immunovant.com

Phone Numbers

Technology Stack

immunovant.com uses 13 technologies across their website including cdnjs, AWS CloudFront, Cloudflare, Google Tag Manager, Google Analytics, and more.

CDN

cdnjs

Cloud & Hosting

AWS CloudFront, Cloudflare

Analytics & Marketing

Google Tag Manager, Google Analytics

Web Standards

Twitter Cards, RSS, PWA

CSS Frameworks

Bootstrap, Tailwind CSS

JavaScript Libraries

AOS, GSAP, jQuery

Traffic & Audience

11.1K
Monthly Visits
39%
Bounce Rate
1.5
Pages/Visit
0:12
Avg. Duration

immunovant.com receives approximately 11.1K monthly visitors and ranks #2,215,539 globally. The website has a bounce rate of 39% with visitors viewing an average of 1.5 pages per visit. Users spend an average of 0:12 on the site.

The majority of immunovant.com's traffic comes from undefined, undefined, .

Frequently Asked Questions

What is immunovant.com?
immunovant.com is a website that you can visit at https://immunovant.com. Use TechList.ai to discover the technologies, analytics, and company information about immunovant.com.
What technologies does immunovant.com use?
immunovant.com uses 13 technologies including cdnjs, AWS CloudFront, Cloudflare, and 7 more. View the full tech stack analysis above.
How do I contact immunovant.com?
You can contact immunovant.com through their contact page.
How popular is immunovant.com?
immunovant.com receives approximately 11.1K monthly visitors and ranks #2,215,539 globally. Traffic is growing by 35.9% month-over-month.

Related Searches

immunovant.com pricingimmunovant.com reviewsimmunovant.com alternativesimmunovant.com loginimmunovant.com careerswhat is immunovant.comimmunovant.com tech stackimmunovant.com contactimmunovant.com vs competitorsimmunovant.com featureshow to use immunovant.comimmunovant.com integrations

This page provides publicly available information about immunovant.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit immunovant.com directly at https://immunovant.com.